Rare diseases
Investigational molecules
Locations
Immune Modulation Study of Rilvegostomig and Pembrolizumab in Patients with Advanced Gastric Cancer
SpainEvaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis
SpainA study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
SpainA study of pembrolizumab, belzutifan, and lenvatinib before main treatment in patients with localized kidney cancer
SpainA study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease
SpainStudy of mesenchymal stromal cells expressing CXCR4 and IL-10 for patients with acute Graft Versus Host Disease who do not respond to steroids or ruxolitinib
SpainA study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer
SpainA study to compare REGN7508 and acetylsalicylic acid for preventing blood clots in adults undergoing elective total knee replacement.
SpainA study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.
SpainA study to evaluate the effectiveness of levosimendan in patients with pulmonary hypertension and heart failure with preserved ejection fraction.
SpainA study to evaluate the safety and effectiveness of AZD9793 in adults with advanced or metastatic liver cancer
SpainA study to evaluate the safety and effectiveness of PTT-4256 and nivolumab in patients with solid tumors.
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
